Gina Quati

Gina Quati has extensive experience in business development and regulatory affairs within the pharmaceutical and life sciences sectors. Currently serving as Director of Business Development at ProPharma since July 2021, Gina has previously held multiple roles at the company, including Associate Director and Business Development Manager. Prior experience includes the position of Patient Safety Alliance Manager at Novartis, focusing on the GX Portfolio on a global scale. Additionally, Gina has worked as a Regulatory Affairs Associate at Sandoz and served in various capacities at ATV Ausbildung Training Vernetzung GmbH, Uniklinik RWTH Aachen, and RWTH Aachen University. Educational qualifications include a Master of Science degree from RWTH Aachen University and ongoing participation in The Pharma Business Development Course at CELforPharma. Further studies in biology have been pursued at the University of Düsseldorf. Gina also has a background in legal studies from Berufskolleg für Wirtschaft und Verwaltung Aachen.